{"slideshow_credits": null, "snippet": "Across the country, there is huge variation in the share of prescription drugs that are generics versus brand-name, leading to wasteful taxpayer spending somewhere.", "abstract": "Across the country, there is huge variation in the share of prescription drugs that are generics versus brand-name, leading to wasteful taxpayer spending somewhere.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Catherine", "role": "reported", "lastname": "RAMPELL", "rank": 1, "organization": ""}], "original": "By CATHERINE RAMPELL"}, "web_url": "http://economix.blogs.nytimes.com/2012/06/04/cheap-vs-expensive-drugs/", "lead_paragraph": null, "headline": {"main": "Cheap vs. Expensive Drugs", "kicker": "Economix"}, "_id": "4fd3a4878eb7c8105d8ef405", "word_count": "677", "multimedia": [], "pub_date": "2012-06-04T15:40:45Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "organizations", "value": "New England Journal of Medicine", "rank": "1"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}, {"name": "subject", "value": "Generic Brands and Products", "rank": "2"}, {"name": "subject", "value": "Medicare", "rank": "3"}], "blog": [], "subsection_name": "Economy", "type_of_material": "Blog"}